MOCHIDA PHARMACEUTICAL CO., LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,215 JPY | 0.00% |
|
+0.31% | -1.68% |
| Apr. 25 | Hidehiro Imatsu named president of Goldman Sachs Japan | RE |
| Mar. 21 | Tranche Update on Mochida Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 15, 2023. | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 102B 655M | Sales 2025 * | 106B 681M | Capitalization | 114B 733M |
|---|---|---|---|---|---|
| Net income 2024 * | 4.4B 28.27M | Net income 2025 * | 5.9B 37.9M | EV / Sales 2024 * | 0.5 x |
| Net cash position 2024 * | 62.97B 405M | Net cash position 2025 * | 64.14B 412M | EV / Sales 2025 * | 0.47 x |
| P/E ratio 2024 * |
25.9
x | P/E ratio 2025 * |
19.4
x | Employees | 1,529 |
| Yield 2024 * |
2.49% | Yield 2025 * |
2.49% | Free-Float | 53.94% |
More Fundamentals
* Assessed data
More news
More news
| 1 week | +0.31% | ||
| Current month | +0.78% | ||
| 1 month | +2.39% | ||
| 3 months | -0.77% | ||
| 6 months | -2.87% | ||
| Current year | -1.68% |
1 week
3 170.00
3 230.00
1 month
3 060.003 230.00
Current year
3 055.003 430.00
1 year
3 055.003 745.00
3 years
3 025.004 000.00
5 years
3 025.005 380.00
10 years
2 985.006 110.00
| Managers | Title | Age | Since |
|---|---|---|---|
Naoyuki Mochida
PSD | President | 65 | 91-03-31 |
| Chief Administrative Officer | 61 | 17-05-31 | |
| Chief Tech/Sci/R&D Officer | 66 | 82-03-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Naoyuki Mochida
PSD | President | 65 | 91-03-31 |
Nana Otsuki
BRD | Director/Board Member | 59 | 21-06-28 |
Keiichi Sagisaka
BRD | Director/Board Member | 66 | 80-03-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.24% | 0 M€ | +10.96% | ||
| 0.02% | 0 M€ | +17.15% | ||
| 0.02% | 0 M€ | +15.35% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-10 | 3,215 | 0.00% | 12 600 |
| 24-05-09 | 3,215 | +0.78% | 19,400 |
| 24-05-08 | 3,190 | -0.47% | 28,500 |
| 24-05-07 | 3,205 | +0.47% | 20,500 |
| 24-05-02 | 3,190 | -0.47% | 13,200 |
Delayed Quote Japan Exchange, May 10, 2024 at 01:26 am EDT
More quotes
Mochida Pharmaceutical Co Ltd is a Japan-based company principally engaged in the production and sale of drugs. The Pharmaceutical-related segment is engaged in the manufacture, purchase and sale of pharmaceutical products. The Company also conducts brokerage and management of real estate properties, the maintenance and management of buildings, the agency of personal affairs, accounting and purchasing businesses. The Healthcare segment is involved in the manufacture, purchase and sale of quasi drugs and cosmetic products.
Sector
Pharmaceuticals
Calendar
2024-05-12
- Q4 2023 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
3,215
JPY
Average target price
3,200
JPY
Spread / Average Target
-0.47%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -1.68% | 733M | |
| +32.36% | 695B | |
| +26.51% | 568B | |
| -4.40% | 361B | |
| +19.46% | 330B | |
| +3.50% | 283B | |
| +16.34% | 239B | |
| +6.68% | 204B | |
| -9.08% | 198B | |
| +8.62% | 168B |
- Stock Market
- Equities
- 4534 Stock